Analyst Jason Gursky reiterated his Buy rating on the shares. His price target is $210 a share, up more than 30% from ...
Nvidia (NASDAQ:NVDA) has had an underwhelming start to 2025, as the AI chip giant grapples with a mix of unfavorable macro ...
Citigroup stock is undervalued, trading at 75.5% of its tangible book value, presenting a strong buying opportunity amid ...
Four-star-rated analyst Daniel Grosslight at Citi reiterated his Sell rating on Hims & Hers Health (HIMS) stock yesterday, ...
The fourth quarter saw Buffett sell off significant chunks of his stakes in financial stocks including Bank of America and ...
Buybacks have historically been an ace in the hole for companies looking to generate stock gains during lean times.
Citigroup (C) ended the recent trading session ... changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank ...
Shares of JPMorgan Chase ( JPM -3.98%), the largest bank in the U.S. by assets, traded nearly 5% lower as of 10:52 a.m. ET.
DexCom (NASDAQ:DXCM – Get Free Report) had its price target increased by equities researchers at Citigroup from $101.00 to ...
Shares of the midcap drug major Akum Drugs and Pharmaceuticals in Wednesday's trade gained over 3 per cent in Wednesday's ...
The S&P 500 nearly fell into correction territory in intraday trading on Tuesday, a day after the index dropped below its 200-day moving average—a "key technical indicator" and gauge of market ...
BJ’s Wholesale Club (NYSE:BJ – Free Report) had its target price increased by Citigroup from $101.00 to $115.00 in a report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results